Aiforia Technologies Plc, Company release, April 2, 2026 at 15:05 p.m. EEST
Aiforia Technologies Plc's Annual General Meeting was held today April 2, 2026 at 10:00 a.m. EEST in Helsinki. The Annual General Meeting approved the financial statements for the financial year 2025 and discharged the members of the Board of Directors as well as the CEO from liability for the financial year 2025. Furthermore, the Annual General Meeting made the following decisions:
Use of the profit shown on the Balance Sheet and the distribution of dividend
The Annual General Meeting resolved that no dividend will be paid for the financial year January 1, 2025-December 31, 2025 and that the loss for the financial year be retained in the retained earnings account.
Remuneration of the members of the Board of Directors
The Annual General Meeting resolved that the remuneration of the Board of Directors shall be as follows:
The members of the Board of Directors shall be paid an annual remuneration of EUR 20,000, excluding the Chair of the Board, whose annual remuneration is EUR 40,000. Remuneration is the same as last year. If the Board of Directors chooses to elect a Vice Chair of the Board from among its members, they shall be paid an annual remuneration of EUR 25,000.
The Chair of the Audit and Remuneration Committee shall be paid a fixed annual remuneration of EUR 4,000 and each member EUR 2,000. Moreover, Board members are also reimbursed reasonable travel expenses related to the duties of the Board of Directors.
Composition of the Board of Directors
The Annual General Meeting resolved that the number of members of the Board of Directors shall be five (5). The following members of the Board of Directors were re-elected as members of the Board of Directors: Johan Lundin, Jerry Jian Hong, Tuomas Tenkanen, Joseph Bernardo, and Minna Koivula.
The term of office of all members of the Board of Directors will expire at the end of the Annual General Meeting 2027.
Remuneration and election of the auditor
The Annual General Meeting resolved that the auditor shall be paid reasonable remuneration in accordance with the invoice approved by the company. The Annual General Meeting reappointed the firm of authorised public accountants PricewaterhouseCoopers Oy, which has appointed APA Martin Grandell as responsible auditor, as the auditor of the company for a term ending at the end of the next Annual General Meeting.
Authorization of the Board of Directors to decide on the issuance of shares
The Annual General Meeting decided not to approve the Board's proposed share issue authorization for the Board.
Authorization of the Board of Directors to decide on issuing option rights and other special rights entitling to shares
The Annual General Meeting authorised the Board of Directors to decide on the issuance of option rights and other special rights entitling to shares, pursuant to Chapter 10 of the Finnish Limited Liability Companies Act as follows:
Under the authorization, option rights and other special rights entitling to a maximum of 500,000 shares may be issued. The option rights and other special rights entitling to shares may be issued in one or more tranches.
The Board of Directors is authorized to resolve on all terms for the issuance of the special rights entitling to shares. The issue of special rights entitling to shares may be a directed issue in deviation from the shareholders' preemptive rights, provided that there is a weighty financial reason for this.
The authorization revokes all previous authorizations to issue special rights entitling to shares. However, the authorization does not invalidate any earlier authorizations entitling to decide on a share issue.
The authorization is valid until the close of the next General Meeting, however no longer than until June 30, 2027.
The minutes of the Annual General Meeting
The minutes of the General Meeting will be available on the company's website by April 16, 2026 at the latest.
Further inquiries:
Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/
Certified Adviser
UB Corporate Finance Ltd
ubcf@unitedbankers.fi
About Aiforia
Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers advanced software solutions that elevate diagnostic capabilities in image analysis, empowering remarkable medical discoveries both today and in the future. With thousands of AI models developed for research use and several diagnostic solutions deployed, Aiforia is making a significant impact on pathology and healthcare. In Europe, Aiforia is the leading provider of CE-IVD marked AI-powered solutions for digital pathology.
Founded in 2013, Aiforia is a publicly traded company with a global presence and thousands of users worldwide. Headquartered in Helsinki, Finland, the company also operates subsidiaries in the United States and France, and maintains a network of local representatives across Europe and North America. Aiforia's diverse team includes experienced AI and software developers, pathologists, medical scientists, and a dedicated commercial team. Together, they are transforming pathology through AI, enabling better care for every patient.
Find out more at www.aiforia.com
